260 related articles for article (PubMed ID: 32329856)
21. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
[TBL] [Abstract][Full Text] [Related]
22. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
23. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
24. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.
Chen XF; Guo JF; Xu JF; Yin SH; Cao WL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7826-7834. PubMed ID: 31599407
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-106a promotes breast cancer progression by regulating DAX-1.
Liu C; Song YH; Mao Y; Wang HB; Nie G
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1574-1583. PubMed ID: 30840280
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-139-5p regulates C2C12 cell myogenesis through blocking Wnt/β-catenin signaling pathway.
Mi L; Li Y; Zhang Q; Zhao C; Peng Y; Yang G; Zheng X
Biochem Cell Biol; 2015 Feb; 93(1):8-15. PubMed ID: 25529604
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
32. In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.
Zhang ZC; Liu JX; Shao ZW; Pu FF; Wang BC; Wu Q; Zhang YK; Zeng XL; Guo XD; Yang SH; He TC
Medicine (Baltimore); 2017 Jul; 96(27):e7245. PubMed ID: 28682874
[TBL] [Abstract][Full Text] [Related]
33. MiR-214 negatively regulates proliferation and WNT/β-catenin signaling in breast cancer.
Yi SJ; Li LL; Tu WB
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5148-5154. PubMed ID: 28051254
[TBL] [Abstract][Full Text] [Related]
34. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
[TBL] [Abstract][Full Text] [Related]
35. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway.
Yang F; Xiao Z; Zhang S
Int J Mol Med; 2018 Dec; 42(6):3355-3363. PubMed ID: 30272253
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling.
Tian H; Wang X; Lu J; Tian W; Chen P
Chem Biol Interact; 2019 Aug; 308():244-251. PubMed ID: 31145890
[TBL] [Abstract][Full Text] [Related]
38. MiR-449b-5p inhibits human glioblastoma cell proliferation by inactivating WNT2B/Wnt/β-catenin signaling pathway.
Hou WZ; Chen XL; Qin LS; Xu ZJ; Liao GM; Chen D; Hu LJ; Mao ZM; -S Huang J; Yuan Q; Liao C; Yao QM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5549-5557. PubMed ID: 32495889
[TBL] [Abstract][Full Text] [Related]
39. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
Feng F; Chen AP; Wang XL; Wu GL
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
[TBL] [Abstract][Full Text] [Related]
40. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
